세계의 낭포성섬유증 폐질환 시장 : 약물 유형별, 투여 경로별, 유통 채널별, 지역별, 국가별 분석, 시장 인사이트 및 예측

Global Cystic Fibrosis Lung Disease Market : Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast

US $ 2,450 ￦ 3,400,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 2,950 ￦ 4,094,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 낭포성섬유증 폐질환 시장 규모는 2022년 107억 5,000만 달러에서 2029년 말에는 468억 7,000만 달러에 달할 것으로 예상되며, 예측 기간인 2024년부터 2029년까지 25.7%의 CAGR로 성장할 것으로 예상됩니다.

시장은 치료 개입의 지속적인 발전에 힘입어 성장하고 있습니다. 제약회사들은 혁신적인 치료법을 앞당기기 위해 연구개발에 많은 투자를 하고 있습니다. 또한, 유전자 치료 및 CFTR 조절제와 같은 새로운 약물과 치료법의 등장으로 낭포성섬유증 환자의 치료 환경이 크게 개선되고 있습니다. 이러한 발전은 환자의 예후를 개선할 뿐만 아니라 전체 시장 성장에도 기여하고 있습니다.

또한, 의료진과 환자들 사이에서 낭포성섬유증에 대한 인식이 높아지는 것도 시장 성장의 중요한 동력이 되고 있습니다. 진단 능력의 향상과 질병 교육에 대한 노력 강화는 조기 발견과 조기 개입에 기여하여 시장 성장에 기여하고 있습니다.

이 보고서는 세계 낭포성섬유증 폐질환 시장에 대해 조사했으며, 시장 규모와 예측, 지역 및 부문 분석, 주요 동향과 기회 등의 정보를 전해드립니다.

목차

제1장 시장 배경

• 범위와 제품 전망
• 주요 요약
• 조사 방법

제2장 전략적 추천사항

제3장 세계의 낭포성섬유증 폐질환 시장 : 실적과 예측(2019-2029년)

• 낭포성섬유증 폐질환 : 팩트 시트
• 파이프라인에 있는 폐 증상을 표적으로 한 낭포성섬유증 치료법
• 낭포성섬유증의 저분자 요법과 그 표적 변이
• CF 환자의 유전자와 약물전달에 일반적으로 사용되는 비바이러스 벡터
• 세계의 낭포성섬유증 폐질환 시장 : 대시보드
• 세계의 낭포성섬유증 폐질환 시장 : 시장 금액 평가(2019-2029년)
• 세계의 낭포성섬유증 폐질환 시장에 대한 COVID-19의 영향
• 세계의 낭포성섬유증 폐질환 시장 세분화 : 약제 유형별
  • 세계의 낭포성섬유증 폐질환 시장, 약제 유형별, 개요
  • 세계의 낭포성섬유증 폐질환 시장 규모 : CFTR 모듈레이터(금액)(2019-2029년)
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 기관지확장제(금액)(2019-2029년)
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 점액용해제(금액)(2019-2029년)
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 항감염제(금액)(2019-2029년)
• 세계의 낭포성섬유증 폐질환 시장 세분화 : 투여 경로별
  • 세계의 낭포성섬유증 폐질환 시장 : 투여 경로별, 개요
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 경구(금액)(2019-2029년)
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 흡입(금액)(2019-2029년)
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 정맥(금액)(2019-2029년)
• 세계의 낭포성섬유증 폐질환 시장 세분화 : 유통 채널별
  • 세계의 낭포성섬유증 폐질환 시장 : 유통 채널별, 개요
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 병원 약국(금액)(2019-2029년)
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 소매 약국(금액)(2019-2029년)
  • 세계의 낭포성섬유증 폐질환 시장 규모 : 온라인 채널(금액)(2019-2029년)

제4장 세계의 낭포성섬유증 폐질환 시장, 지역 분석

• 연구 지역 범위
• 지역 현황

제5장 아메리카의 낭포성섬유증 폐질환 시장 : 실적과 예측(2019-2029년)

• 아메리카의 낭포성섬유증 폐질환 시장 : 현황
• 아메리카의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
• 아메리카의 낭포성섬유증 폐질환 시장 : 주요 요인
• 아메리카의 낭포성섬유증 폐질환 시장 : 부문 분석
• 아메리카의 낭포성섬유증 폐질환 시장 세분화 : 약제 유형별
• 아메리카의 낭포성섬유증 폐질환 시장 세분화 : 투여 경로별
• 아메리카의 낭포성섬유증 폐질환 시장 세분화 : 유통 채널별
• 아메리카의 낭포성섬유증 폐질환 시장 세분화 : 국가별
  • 미국의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 캐나다의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 기타 아메리카의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)

제6장 유럽의 낭포성섬유증 폐질환 시장 : 실적과 예측(2019-2029년)

• 유럽의 낭포성섬유증 폐질환 시장 : 현황
• 유럽의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
• 유럽의 낭포성섬유증 폐질환 시장 : 주요 요인
• 유럽의 낭포성섬유증 폐질환 시장 : 부문 분석
• 유럽의 낭포성섬유증 폐질환 시장 세분화 : 약제 유형별
• 유럽의 낭포성섬유증 폐질환 시장 세분화 : 투여 경로별
• 유럽의 낭포성섬유증 폐질환 시장 세분화 : 유통 채널별
• 유럽의 낭포성섬유증 폐질환 시장 세분화 : 국가별
  • 독일의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 영국의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 프랑스의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 이탈리아의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 스페인의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 기타 유럽의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)

제7장 아시아태평양의 낭포성섬유증 폐질환 시장 : 실적과 예측(2019-2029년)

• 아시아태평양의 낭포성섬유증 폐질환 시장 : 현황
• 아시아태평양의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
• 아시아태평양의 낭포성섬유증 폐질환 시장 : 주요 요인
• 아시아태평양의 낭포성섬유증 폐질환 시장 : 부문 분석
• 아시아태평양의 낭포성섬유증 폐질환 시장 세분화 : 약제 유형별
• 아시아태평양의 낭포성섬유증 폐질환 시장 세분화 : 투여 경로별
• 아시아태평양의 낭포성섬유증 폐질환 시장 세분화 : 유통 채널별
• 아시아태평양의 낭포성섬유증 폐질환 시장 세분화 : 국가별
  • 중국의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 호주의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 인도의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
  • 기타 아시아태평양의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)

제8장 중동 및 아프리카의 낭포성섬유증 폐질환 시장 : 실적과 예측(2019-2029년)

• 중동 및 아프리카의 낭포성섬유증 폐질환 시장 : 현황
• 중동 및 아프리카의 낭포성섬유증 폐질환 시장 : 시장 규모와 CAGR(2019-2029년)
• 중동 및 아프리카의 낭포성섬유증 폐질환 시장 : 주요 요인
• 중동 및 아프리카의 낭포성섬유증 폐질환 시장 : 부문 분석
• 중동 및 아프리카의 낭포성섬유증 폐질환 시장 세분화 : 약제 유형별
• 중동 및 아프리카의 낭포성섬유증 폐질환 시장 세분화 : 투여 경로별
• 중동 및 아프리카의 낭포성섬유증 폐질환 시장 세분화 : 유통 채널별

제9장 시장 역학

• 세계의 낭포성섬유증 폐질환 시장에 대한 시장 역학의 영향 평가
• 성장 촉진요인
• 성장 억제요인
• 동향

제10장 Porter's Five Forces 분석

제11장 경쟁 포지셔닝

• 기업의 제품 포지셔닝
• 시장 포지션 매트릭스
• 낭포성섬유증 폐질환 시장의 시장 점유율 분석
• 기업 개요
  • Vertex Pharmaceuticals
  • Gsk plc
  • Novartis AG
  • Roche Holding AG
  • Bayer AG
  • Gilead Sciences
  • Chiesi Farmaceutici S.p.A.
  • Enterprise Therapeutics
  • Laurent Pharma

ksm

영문 목차

영문목차

Executive Summary

Azoth Analytics has released a research report titled "Cystic Fibrosis Lung Disease Market (2024 Edition)" which provides a complete analysis of the global Cystic Fibrosis Lung Disease industry in terms of market segmentation by Drug Type (CFTR Modulators, Bronchodilators, Mucolytics, Anti-infectives) and By Route of Administration (Oral, Inhalation, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Australia, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. During the forecast period, 2024-2029, the Global Cystic Fibrosis Lung Disease market is expected to grow at a CAGR of 25.7%. The Global Cystic Fibrosis Lung Disease Market is expected to generate USD 46.87 Billion by the end of 2029, up from USD 10.75 Billion in 2022.

The cystic fibrosis lung disease market is propelled by continuous advancements in therapeutic interventions. Pharmaceutical companies are investing heavily in research and development to bring innovative treatments to the forefront. Moreover, the emergence of novel drugs and therapies, such as gene therapies and CFTR modulators, has significantly improved the treatment landscape for cystic fibrosis patients. These advancements not only enhance patient outcomes but also contribute to the overall growth of the market.

Additionally, the rising awareness of cystic fibrosis among healthcare professionals and patients is a significant driver for market growth. Improved diagnostic capabilities and increased disease education efforts contribute to early detection and intervention which is contributing to the market growth.

Scope of the Report

• The report analyses the Cystic Fibrosis Lung Disease Market by Value (USD Billion).
• The report presents the analysis of the Cystic Fibrosis Lung Disease Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Cystic Fibrosis Lung Disease Market by Drug Type (CFTR Modulators, Bronchodilators, Mucolytics).
• The report analyses the Cystic Fibrosis Lung Disease Market By Route of Administration (Oral, Inhalation, Intravenous)
• The report analyses the Cystic Fibrosis Lung Disease Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, Drug Type, Route of Administration and Distribution Channels.
• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
• The report also analyses the pipeline framework of the Dugs for the Cystic Fibrosis Lung Disease
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Vertex Pharmaceuticals, Gsk plc, Novartis AG, Roche Holding AG, Bayer AG, Gilead Sciences, Chiesi Farmaceutici S.p.A., Enterprise Therapeutics, and Laurent Pharma.

Table of Contents

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Strategic Recommendations

3. Global Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

• 3.1 Cystic Fibrosis Lung Disease: Fact Sheet
• 3.2 Cystic fibrosis therapies targeting Lung symptoms in Pipeline
• 3.3 Cystic fibrosis small molecule therapies and their targeted mutations
• 3.4 Non-viral vectors commonly used for gene and drug delivery in CF patients
• 3.5 Global Cystic Fibrosis Lung Disease Market: Dashboard
• 3.6 Global Cystic Fibrosis Lung Disease Market: Market Value Assessment, 2019H-2029F (USD Billion)
• 3.7 Impact of COVID-19 on Global Cystic Fibrosis Lung Disease Market
• 3.8 Global Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
  • 3.8.1 Global Cystic Fibrosis Lung Disease Market, By Drug Type Type Overview
  • 3.8.2 Global Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8.3 Global Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8.4 Global Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8.5 Global Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
• 3.9 Global Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
  • 3.9.1 Global Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
  • 3.9.2 Global Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.3 Global Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.4 Global Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
• 3.10 Global Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
  • 3.10.1 Global Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
  • 3.10.2 Global Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.10.3 Global Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.10.4 Global Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Cystic Fibrosis Lung Disease Market, Regional Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

• 5.1 Americas Cystic Fibrosis Lung Disease Market: Snapshot
• 5.2 Americas Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
• 5.3 Americas Cystic Fibrosis Lung Disease Market: Key Factors
• 5.4 Americas Cystic Fibrosis Lung Disease Market : Segment Analysis
• 5.5 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
  • 5.5.1 Americas Cystic Fibrosis Lung Disease Market, By Drug Type Overview
  • 5.5.2 Americas Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.3 Americas Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.4 Americas Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.5 Americas Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.6 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
  • 5.6.1 Americas Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
  • 5.6.2 Americas Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.6.3 Americas Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.6.4 Americas Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.7 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
  • 5.7.1 Americas Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
  • 5.7.2 Americas Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.3 Americas Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.4 Americas Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.8 Americas Cystic Fibrosis Lung Disease Market Segmentation : By Country
  • 5.8.1 United States Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 5.8.1.1 United States Cystic Fibrosis Lung Disease Market, By Drug Type
    • 5.8.1.2 United States Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 5.8.1.3 United States Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 5.8.2 Canada Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 5.8.2.1 Canada Cystic Fibrosis Lung Disease Market, By Drug Type
    • 5.8.2.2 Canada Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 5.8.2.3 Canada Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 5.8.3 Rest of Americas Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 5.8.3.1 Rest of Americas Cystic Fibrosis Lung Disease Market, By Drug Type
    • 5.8.3.2 Rest of Americas Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 5.8.3.3 Rest of Americas Cystic Fibrosis Lung Disease Market, By Distribution Channel

6. Europe Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

• 6.1 Europe Cystic Fibrosis Lung Disease Market: Snapshot
• 6.2 Europe Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
• 6.3 Europe Cystic Fibrosis Lung Disease Market: Key Factors
• 6.4 Europe Cystic Fibrosis Lung Disease Market: Segment Analysis
• 6.5 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
  • 6.5.1 Europe Cystic Fibrosis Lung Disease Market, By Drug Type Overview
  • 6.5.2 Europe Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.3 Europe Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.4 Europe Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.5 Europe Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.6 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
  • 6.6.1 Europe Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
  • 6.6.2 Europe Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.6.3 Europe Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.6.4 Europe Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.7 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
  • 6.7.1 Europe Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
  • 6.7.2 Europe Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.7.3 Europe Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.7.4 Europe Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.8 Europe Cystic Fibrosis Lung Disease Market Segmentation : By Country
  • 6.8.1 Germany Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 6.8.1.1 Germany Cystic Fibrosis Lung Disease Market, By Drug Type
    • 6.8.1.2 Germany Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 6.8.1.3 Germany Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 6.8.2 United Kingdom Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 6.8.2.1 United Kingdom Cystic Fibrosis Lung Disease Market, By Drug Type
    • 6.8.2.2 United Kingdom Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 6.8.2.3 United Kingdom Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 6.8.3 France Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 6.8.3.1 France Cystic Fibrosis Lung Disease Market, By Drug Type
    • 6.8.3.2 France Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 6.8.3.3 France Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 6.8.4 Italy Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 6.8.4.1 Italy Cystic Fibrosis Lung Disease Market, By Drug Type
    • 6.8.4.2 Italy Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 6.8.4.3 Italy Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 6.8.5 Spain Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 6.8.5.1 Spain Cystic Fibrosis Lung Disease Market, By Drug Type
    • 6.8.5.2 Spain Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 6.8.5.3 Spain Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 6.8.6 Rest of Europe Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 6.8.6.1 Rest of Europe Cystic Fibrosis Lung Disease Market, By Drug Type
    • 6.8.6.2 Rest of Europe Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 6.8.6.3 Rest of Europe Cystic Fibrosis Lung Disease Market, By Distribution Channel

7. Asia-Pacific Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

• 7.1 Asia-Pacific Cystic Fibrosis Lung Disease Market: Snapshot
• 7.2 Asia-Pacific Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
• 7.3 Asia-Pacific Cystic Fibrosis Lung Disease Market: Key Factors
• 7.4 Asia-Pacific Cystic Fibrosis Lung Disease Market: Segment Analysis
• 7.5 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
  • 7.5.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Drug Type Overview
  • 7.5.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.5 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.6 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
  • 7.6.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
  • 7.6.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.6.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.6.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.7 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation : By Distribution Channel
  • 7.7.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
  • 7.7.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.8 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation : By Country
  • 7.8.1 China Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 7.8.1.1 China Cystic Fibrosis Lung Disease Market, By Drug Type
    • 7.8.1.2 China Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 7.8.1.3 China Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 7.8.2 Australia Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 7.8.1.1 Australia Cystic Fibrosis Lung Disease Market, By Drug Type
    • 7.8.1.2 Australia Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 7.8.1.3 Australia Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 7.8.3 India Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 7.8.3.1 India Cystic Fibrosis Lung Disease Market, By Drug Type
    • 7.8.3.2 India Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 7.8.3.3 India Cystic Fibrosis Lung Disease Market, By Distribution Channel
  • 7.8.5 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
    • 7.8.5.1 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market, By Drug Type
    • 7.8.5.2 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market, By Route of Administration
    • 7.8.5.3 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market, By Distribution Channel

8. Middle-East & Africa Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

• 8.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Snapshot
• 8.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
• 8.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Key Factors
• 8.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Segment Analysis
• 8.5 Middle-East & Africa Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
  • 8.5.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market, By Drug Type Overview
  • 8.5.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.5.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.5.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.5.5 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Anti-infectives, By Value, 2019H-2029F (USD Billion & CAGR)
• 8.6 Middle-East & Africa Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
  • 8.6.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
  • 8.6.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
• 8.6 Middle-East & Africa Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
  • 8.6.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market, By Distribution Channel: Overview
  • 8.6.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

• 9.1 Impact Assessment of Market Dynamics on Global Cystic Fibrosis Lung Disease Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Porter's Five Forces Analysis

11. Competitive Positioning

• 11.1 Companies' Product Positioning
• 11.2 Market Position Matrix
• 11.3 Market Share Analysis of Cystic Fibrosis Lung Disease Market
• 11.4 Company Profiles
  • 11.4.1 Vertex Pharmaceuticals
  • 11.4.2 Gsk plc
  • 11.4.3 Novartis AG
  • 11.4.4 Roche Holding AG
  • 11.4.5 Bayer AG
  • 11.4.6 Gilead Sciences
  • 11.4.7 Chiesi Farmaceutici S.p.A.
  • 11.4.8 Enterprise Therapeutics
  • 11.4.9 Laurent Pharma

관련자료